Surgery Partners, Inc. (SGRY) Tops Q4 EPS by 7c

Surgery Partners, Inc. (NASDAQ: SGRY) reported Q4 EPS of $0.27, $0.07 better than the analyst estimate of $0.20. Revenue for the quarter came in at $707.1 million versus the consensus estimate of $688.06 million.

GUIDANCE:

Surgery Partners, Inc. sees Q1 2023 revenue of greater than $2.75 billion, versus the consensus of $2.81 billion.

For earnings history and earnings-related data on Surgery Partners, Inc. (SGRY) click here.

You May Also Be Interested In

• WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance
• Simulations Plus (SLP) Tops Q3 EPS by 7c
• PSQ Holdings announces 1-for-15 reverse stock split effective July 13